Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-12 Sale |
2024-12-13 7:53 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,605 | $12.23 | $1,768,093 | 310,888 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 5:41 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
50,000 | $13.15 | $657,625 | 136,380 (Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 7:15 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,640 | $14.11 | $2,041,200 | 436,020 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 9:45 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
90,000 | $13.43 | $1,208,619 | 334,280 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 4:11 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
100,000 | $14.12 | $1,411,742 | 136,380 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
274,100 | $0 | 274,100 (Direct) |
View |
| 2024-12-13 Exercise |
2024-12-13 7:53 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
27,272 | $1.44 | 310,888 (Direct) |
View |
| 2024-12-12 Exercise |
2024-12-13 7:53 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
117,333 | $0.84 | 310,888 (Direct) |
View |
| 2024-12-12 Exercise |
2024-12-13 7:53 pm |
N/A 2029-07-04 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,605 | $0 | 310,888 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:41 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
50,000 | $0.84 | 136,380 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:41 pm |
N/A 2029-07-04 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
50,000 | $0 | 136,380 (Direct) |
View |
| 2024-12-04 Exercise |
2024-12-06 7:15 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,640 | $0.84 | 436,020 (Direct) |
View |
| 2024-12-04 Exercise |
2024-12-06 7:15 pm |
N/A 2029-07-04 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
144,640 | $0 | 436,020 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:45 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
90,000 | $0.84 | 334,280 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 9:45 pm |
N/A 2029-12-16 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
90,000 | $0 | 334,280 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:41 pm |
N/A 2034-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2022-11-08 Option Award |
2022-11-10 6:00 pm |
N/A 2029-07-05 |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
603,753 | $0 | 840,133 (Direct) |
View |